2024-09-18 - Analysis Report
##  ISRG Stock Analysis Report

**Company Overview:** Intuitive Surgical, Inc. (ISRG) is a medical device company that develops, manufactures, and markets robotic surgical systems.

**1. Performance Analysis:**

* **Cumulative Return:** ISRG has generated a cumulative return of 103.8%, outperforming the S&P 500 (VOO) by 14.78% (cumulative return of 89.02%). 
* **Relative Strength:** ISRG's current relative strength compared to the S&P 500 is at the 60.77th percentile of its historical performance range. This suggests that ISRG is currently outperforming the broader market but not at an exceptionally strong level.

**2. Recent Price Movements:**

* **Closing Price:** $491.39
* **5-Day Moving Average:** $490.09
* **20-Day Moving Average:** $484.84
* **60-Day Moving Average:** $459.59

The stock price is slightly above its 5-day moving average, indicating potential short-term bullish sentiment. However, the price is also above its 20-day and 60-day moving averages, suggesting a longer-term upward trend. 

**3. Technical Indicators:**

* **RSI:** 59.78 - The RSI is within the neutral range (30-70), suggesting that the stock is neither overbought nor oversold.
* **PPO:** -0.11 - The PPO is slightly negative, indicating a potential minor downtrend. 
* **Delta_Previous_Relative_Divergence:** 2.07 - The positive value suggests a potential short-term upward trend. 
* **Expected_Return:** 16.79% - This represents a potential maximum 5-year expected return on invested capital.

**4. Recent Earnings and Outlook:**

| Date | EPS | Revenue | 
|---|---|---|
| 2024-07-19 | 1.48 | 2.01 B$ | 
| 2024-04-19 | 1.54 | 1.89 B$ | 
| 2023-10-20 | 1.18 | 1.74 B$ | 
| 2023-07-24 | 1.20 | 1.76 B$ | 
| 2024-07-19 | 1.20 | 1.76 B$ |

Intuitive Surgical has consistently surpassed revenue expectations in recent quarters. The most recent earnings report showed a slight miss on EPS, but still demonstrated solid revenue growth. The company remains optimistic about future growth, driven by increasing adoption of robotic surgical systems and a growing global market.

**5. Overall Analysis:**

ISRG has been a strong performer, outperforming the S&P 500 with a solid cumulative return. The stock price is currently in an upward trend with strong technical indicators. The recent earnings report showcased solid revenue growth and a positive outlook. 

**6. Conclusion:**

ISRG remains a promising investment opportunity, demonstrating a healthy balance of past performance, current market strength, and positive future prospects. Its strong position in the robotic surgery market and its focus on innovation make it a compelling investment for investors seeking growth and long-term potential. 
